Navigation Links
Valtech Cardio Ltd. Completes $17.8 Million in Series B Financing
Date:2/2/2010

OR YEHUDA, Israel, Feb. 2 /PRNewswire/ -- Valtech Cardio Ltd. announced today that new and existing investors (OXO Capital Valve Ventures LLC, NGN Biomed Opportunity II, L.P., and Peregrine VC Investments II, L.P.) recently completed a Series B financing of $17.8 million.

Valtech Cardio Ltd. (Valtech) is engaged in development of a portfolio of minimally-invasive surgical and transcatheter mitral valve repair and replacement technologies designed to correct or significantly improve mitral valve function in ways that reduce or eliminate mitral regurgitation (MR).  MR is a serious heart disorder characterized by incomplete closure of the mitral valve.  The valve leakage (from the left ventricle into the left atrium), often called regurgitation, reduces the amount of blood that is pumped out of the heart during each contraction and is associated with other serious medical conditions, including atrial fibrillation.  MR is believed to be the most common form of valvular heart disease.

"The enthusiastic support from our investor group provides us with the capital necessary to complete development and initial clinical evaluation of several products designed to dramatically improve mitral valve function," said Amir Gross, Founder and Chief Operating Officer of Valtech.  "The Valtech team is focused on improved annuloplasty and chordal repair technologies that will help physicians more effectively treat their patients undergoing surgical (open and minimally-invasive) and percutaneous transcatheter mitral valve repair procedures," Gross commented.

"The medical community has clearly articulated the need for advanced mitral valve repair and replacement solutions," said Lawrence C. Best, Executive Chairman of the Board.  "The mitral valve repa
'/>"/>

SOURCE Valtech Cardio Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
2. CardioFocus Endoscopic Ablation System Earns CE Mark to Treat Atrial Fibrillation; US Clinical Investigation Underway
3. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
4. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
5. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
6. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
7. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
8. Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease
9. Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial
10. Cardiologists Tackle Next Frontier in Cardiovascular Disease
11. Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Inc. (NASDAQ: CPIX ), a specialty ... gastroenterology, today announced fourth quarter and annual 2014 ... 2014 to $37 million, resulting in Adjusted Earnings ... At the end of 2014, Cumberland had total ... in cash and investments, with no debt. ...
(Date:3/3/2015)... , March 3, 2015   Surefire Medical, ... prospective clinical trial comparing the Surefire Infusion System with ... primary or metastatic liver cancer, using the Surefire ... of embolic agents, and with significantly decreased uptake ... today at the Society of Interventional Radiology ...
(Date:3/3/2015)... AUSTIN, Texas , March 3, 2015  UnaliWear ... that provides advanced support for seniors that guards against ... The new wearable – the Kanega ... of its kind to use an easy speech interface ... update medical information without human input. ...
Breaking Medicine Technology:Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 2Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 3Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 4Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 5Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 6Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 7Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 8Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 9Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 10Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 11Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 12Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 13Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 14Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 15Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 16Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 17Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 18Clinical Trial Comparing the Surefire Infusion Device to an End Hole Catheter Finds Surefire Increases Tumor Uptake and Decreases Non-Target Embolization In Every Patient, Multiple Liver Cancer Types 2UnaliWear's Wearable For Seniors Extends Independence With Advanced Technology 2
... WIRE)--Mar 19, 2007 - Acorda,Therapeutics (Nasdaq: ACOR) today ... Sclerosis Center at the University,of Rochester, will present ... Fampridine-SR in multiple sclerosis at the,upcoming American Academy ... place on Wednesday May 2, 2007 at 4:15 ...
... 2007 - Nymox,Pharmaceutical Corporation (NASDAQ: NYMX) today ... outcome study of NX-1207,for benign prostatic hyperplasia ... and 116 unselected subjects participated in the,blinded, ... scores and treatment outcome 8-19,months after NX-1207 ...
Cached Medicine Technology:Acorda Therapeutics Presentation of Fampridine-SR Phase 3 Data,Selected for Scientific Highlights Program at the American Academy,of Neurology Meeting 2Nymox Announces Positive Results from Newly Completed Long-term,Study of NX-1207 for Benign Prostatic Hyperplasia 2Nymox Announces Positive Results from Newly Completed Long-term,Study of NX-1207 for Benign Prostatic Hyperplasia 3
(Date:3/4/2015)... (PRWEB) March 04, 2015 The week ... Awareness Week with World Sleep Awareness Day being recognized ... to the health and financial risks associated with sleep ... the Sleep Apnea Treatment Centers of America have turned ... educational articles, they hope will virally inspire conversation regarding ...
(Date:3/4/2015)... Alexandria, VA (PRWEB) March 04, 2015 ... had surprising results. When asked —“What retirement cost ... many respondents said healthcare and prescription costs were most ... and utilities, another 40%. Sixteen percent said nourishing ... cost. , “This poll is important because it illustrates ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Follow ... worrisome public health issue worldwide. The rising prevalence of ... and social burden in both developed and developing countries. ... projected to rise to 1.5 billion, equating to approximately ... these patients are forecast to come from the developing ...
(Date:3/4/2015)... 2015 Theme and plugin developers from ... for Final Cut Pro X entitled ProFont NoteBook , “ProFont ... any FCPX editors project.” Said Christiana Austin, CEO of Pixel ... add animated font to their FCPX media.” , With ProFont ... within Final Cut Pro X. ProFont Notebook offers users up ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Bird B ... industrial and residential applications now offers its popular plastic ... The humane, highly efficient bird deterrent is ... match the color and décor of the building or ... colors—brick red, white, crystal clear, light grey, brown, black ...
Breaking Medicine News(10 mins):Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 2Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 3Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 4Health News:Most Difficult Cost In Retirement? Retirees Evenly Split Between Housing and Healthcare, Says New Poll By The Senior Citizens League 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 3Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 4Health News:Announcing a New Title Pack from Pixel Film Studios, ProFont NoteBook for Final Cut Pro X 2Health News:Plastic Bird Spikes Now Come in 7 Colors to Blend in With Their Surroundings 2
... 2011)Approximately 10-20 percent of prostate cancer patients have a family ... that are used to evaluate the extent and aggressiveness of ... the Prostate Specific Antigen Level (PSA), Gleason score (GS) from ... However, men with a family history of prostate cancer have ...
... , WEDNESDAY, Oct. 5 (HealthDay News) -- Smokers have ... are more likely than men to suffer complications after a ... data on 3,588 patients admitted to the University of Michigan ... attack. About 24 percent of the patients were current smokers. ...
... A tracheostomy performed within the first seven days after a ... to a team of Penn State College of Medicine researchers. ... chance of surviving when admitted to the hospital. A ... neck directly into the trachea to allow unimpeded breathing. (A ...
... Therapeutics will be held from Nov. 12-16, 2011, at ... This unique conference combines the efforts of the American ... the European Organisation for the Research and Treatment of ... to focus exclusively on issues of drug development as ...
... New Tool That Helps Identify Prostate Cancer Patients with ... (October 4, 2011)After a prostate cancer patient receives radiation ... antigen, or PSA, in his blood. An increase in ... of the cancer,s return to the prostate. Fox Chase ...
... video games, already known to improve motor function in,recovering ... in intensive care units (ICU), new research from Johns,Hopkins ... Journal of Critical Care ,researchers studied the safety ... therapy in the ICU. "Patients admitted to our ...
Cached Medicine News:Health News:More aggressive treatment not necessary for men with a family history of prostate cancer 2Health News:Earlier tracheostomies result in better patient outcomes 2Health News:New tool helps identify prostate cancer patients with highest risk of death 2Health News:Practical play: Interactive video games appear valuable for ICU patients 2
... fiberoptic laryngoscope blade that can give that ... during difficult intubations. The articulating tip design ... be raised by squeezing a lever next ... a more complete exposure of the glottis, ...
... The FR-120F, Fujinon's new fiberoptic Naso-Pharyngo-Laryngoscope ... and patient comfort. The latest in ... an increased light guide, and a wide ... very impressive 3.3mm distal tip diameter. ...
... Articulating Tip Laryngoscopes are the ... Industry. The articulating tip aids ... an improved view of epiglottis. ... Optic styles. We guarantee your ...
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
Medicine Products: